Concomitant PPI and Advanced Therapy Linked to Worse Outcomes in IBD

Researchers at DDW 2022 found that coadministration of PPIs and advanced therapy in patients with IBD resulted in poor clinical outcomes.

Related Keywords

California ,United States ,San Diego , ,Ibm ,Digestive Disease Week ,Scan Databases ,